VOR BIOPHARMA INC (VOR) Stock Analyst Ratings
USA - NASDAQ:VOR - US9290331084 - Common Stock
29.73 USD
+0.73 (+2.52%)
ChartMill assigns a Buy % Consensus number of 76% to VOR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 36.47. This target is 22.65% above the current price.
VOR was analyzed by 9 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about VOR.
In the previous month the buy percentage consensus was at a similar level.
VOR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-15 | Baird | Upgrade | Neutral -> Outperform |
| 2025-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-30 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2025-06-27 | Baird | Maintains | Neutral -> Neutral |
| 2025-06-26 | Wedbush | Reiterate | Neutral -> Neutral |
| 2025-05-09 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2025-05-09 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-03-21 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2025-03-21 | Stifel | Maintains | Buy -> Buy |
| 2025-03-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-06 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-13 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-13 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-10 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-21 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-21 | Stifel | Maintains | Buy -> Buy |
| 2024-03-21 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-18 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-08-14 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-08-11 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |